全文获取类型
收费全文 | 4499篇 |
免费 | 241篇 |
国内免费 | 10篇 |
专业分类
耳鼻咽喉 | 50篇 |
儿科学 | 162篇 |
妇产科学 | 29篇 |
基础医学 | 563篇 |
口腔科学 | 120篇 |
临床医学 | 297篇 |
内科学 | 934篇 |
皮肤病学 | 65篇 |
神经病学 | 513篇 |
特种医学 | 198篇 |
外科学 | 661篇 |
综合类 | 198篇 |
预防医学 | 222篇 |
眼科学 | 75篇 |
药学 | 331篇 |
中国医学 | 6篇 |
肿瘤学 | 326篇 |
出版年
2023年 | 34篇 |
2022年 | 51篇 |
2021年 | 125篇 |
2020年 | 51篇 |
2019年 | 91篇 |
2018年 | 116篇 |
2017年 | 85篇 |
2016年 | 86篇 |
2015年 | 108篇 |
2014年 | 155篇 |
2013年 | 206篇 |
2012年 | 289篇 |
2011年 | 310篇 |
2010年 | 163篇 |
2009年 | 169篇 |
2008年 | 236篇 |
2007年 | 242篇 |
2006年 | 263篇 |
2005年 | 217篇 |
2004年 | 203篇 |
2003年 | 196篇 |
2002年 | 153篇 |
2001年 | 120篇 |
2000年 | 103篇 |
1999年 | 94篇 |
1998年 | 64篇 |
1997年 | 57篇 |
1996年 | 54篇 |
1995年 | 29篇 |
1994年 | 50篇 |
1993年 | 40篇 |
1992年 | 61篇 |
1991年 | 56篇 |
1990年 | 41篇 |
1989年 | 40篇 |
1988年 | 41篇 |
1987年 | 51篇 |
1986年 | 41篇 |
1985年 | 39篇 |
1984年 | 29篇 |
1983年 | 26篇 |
1982年 | 13篇 |
1981年 | 17篇 |
1980年 | 16篇 |
1979年 | 10篇 |
1978年 | 13篇 |
1977年 | 7篇 |
1976年 | 8篇 |
1975年 | 14篇 |
1967年 | 6篇 |
排序方式: 共有4750条查询结果,搜索用时 156 毫秒
71.
背景:银屑病对患者心理和情绪影响很大。依那西普治疗银屑病患者临床症状有效,作者评估了该药对银屑病相关疲劳和抑郁症状的疗效。方法:618例中至重度银屑病患者接受安慰剂或依那西普50mg(2次/周)双盲治疗。主要疗效终点:治疗12周时,银屑病面积和严重度指数评分较基线改善达75%(PASI 75)或更高水平;次要和其他疗效终点:慢性病治疗疲劳功能评估(FACIT-F)分级、Hamilton抑郁量表(Ham-D)分级、Beck抑郁列表(BDI)及不良事件。根据分组治疗进行疗效分析。基于实际接受治疗的情况对安全性资料进行分析和总结。 相似文献
72.
73.
Warren D Taylor Douglas R McQuoid David C Steffens K Ranga Rama Krishnan 《Neuropsychopharmacology》2004,29(12):2272-2277
Remission of depressive symptoms is the goal of all antidepressant therapy. Rating scales define remission in clinical trials, but it is unclear how well these definitions predict risk of later relapse. We measured the sensitivity and specificity of a range of Montgomery-Asberg Depression Rating Scale (MADRS) cutoff scores at 3- and 6-months, wherein scores above a given cutoff would predict relapse over an 18-month period. We examined 153 elderly depressed subjects exhibiting a MADRS < or = 15 after 3 or 6 months of antidepressant therapy. Subjects who subsequently exhibited a MADRS > 15 during the 18-month study period were defined as relapsed. Receiver operating characteristic (ROC) curves were developed and area under the curve (AUC) values calculated for the sensitivity and specificity of 3- and 6-month MADRS scores to predict future relapse. The 3-month ROC had an AUC value of 0.63; the 6-month ROC had an AUC value of 0.66. There was no MADRS cutoff found that could predict likelihood of relapse with good sensitivity and specificity. A post hoc analysis where relapse rate was adjusted by controlling for medical comorbidity, disability, and social support showed no change in the ROCs or AUC values. The higher the MADRS score at 3 and 6 months, the greater the likelihood of relapse. With no clean MADRS cutoff score, the goal of antidepressant therapy should be the lowest possible degree of depressive symptomatology to minimize risk of later relapse. Definitions of remission that are better associated with longer-term outcomes are needed. 相似文献
74.
Krishnan Swaminathan Ganesh Veerasekar Sujatha Kuppusamy Mohanraj Sundaresan Nalla G Palaniswami 《International journal of diabetes in developing countries.》2018,38(4):456-460
The aim of this study is to assess the associations between glycosylated hemoglobin in the prediabetes range and cardiovascular risk markers in a rural South Indian population. Local Ethics Committee approval and informed consent was obtained from all participants. Inclusion criteria were participants, aged ≥20 and ≤85 years, from Nallampatti, a classical farming village from Tamil Nadu State, India. Those with known history of diabetes were excluded from this analysis. All participants were administered a detailed questionnaire, had anthropometric measurements including height, weight, and waist circumference. Bloods were drawn for random blood glucose, glycosylated hemoglobin, nonfasting lipid profile, cystatin C, uric acid, and hemoglobin. All participants had carotid intima thickness done by high-resolution B-mode carotid ultrasound. Progressive hyperglycemia across the glucose tolerance continuum based on glycosylated hemoglobin levels in a rural South Indian population seems to be associated with worsening cardiovascular risk markers. A cut-off value of ≥6% (42 mmol/mol) seems to herald a much more significant increase in such markers. Long-term follow-up of this cohort for incident cardiovascular disease will help to substantiate the associations between glycosylated hemoglobin levels within the prediabetes range and cardiovascular disease in an Indian population. Evidence-based race-specific criteria for diagnosis of prediabetes and diabetes are the need of the hour for risk stratification and appropriate management. 相似文献
75.
76.
77.
78.
Cerebral microbleeds have emerged as an important new imaging marker of cerebral small vessel disease. With the development of MRI techniques that are exquisitely sensitive to paramagnetic blood products, such as T2*-weighted gradient-recalled echo and susceptibility-weighted sequences, microbleeds have been detected in ever-increasing numbers of patients in stroke and cognitive clinics, as well as in healthy older people and in a variety of other rarer diseases and syndromes. Detection of cerebral microbleeds has clinical implications with respect to the diagnosis of the underlying small vessel disease, the safety of antithrombotic use, and the risk of symptomatic intracerebral haemorrhage, cognitive impairment and dementia. This article provides a guide to the detection and clinical relevance of cerebral microbleeds in different conditions based on a comprehensive review of the literature and own findings in research and clinical practice. 相似文献
79.
Adrian Baranchuk Marwan M. Refaat Kristen K. Patton Mina K. Chung Kousik Krishnan Valentina Kutyifa Gaurav Upadhyay John D. Fisher Dhanunjaya R. Lakkireddy 《Journal of the American College of Cardiology》2018,71(11):1284-1288
Medical devices have been targets of hacking for over a decade, and this cybersecurity issue has affected many types of medical devices. Lately, the potential for hacking of cardiac devices (pacemakers and defibrillators) claimed the attention of the media, patients, and health care providers. This is a burgeoning problem that our newly electronically connected world faces. In this paper from the Electrophysiology Section Council, we briefly discuss various aspects of this relatively new threat in light of recent incidents involving the potential for hacking of cardiac devices. We explore the possible risks for the patients and the effect of device reconfiguration in an attempt to thwart cybersecurity threats. We provide an outline of what can be done to improve cybersecurity from the standpoint of the manufacturer, government, professional societies, physician, and patient. 相似文献
80.